BLM
PCRX icon

Bennett Lawrence Management’s Pacira BioSciences PCRX Stock Holding History

Bennett Lawrence Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$478K Buy
+6,230
New +$353K 0.15% 83
2015
Q2 		– Sell
-4,200
Closed -$373K – 94
2015
Q1 		$373K Buy
+4,200
New +$426K 0.1% 82

Other funds holding PCRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HCM
Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bennett Lawrence Management's PCRX Position: Q4 2015 in Review

Bennett Lawrence Management opened a new position in Pacira BioSciences (PCRX) in Q4 2015: 6,230 shares worth $478K. The stake represents 0.15% of the portfolio and ranks #83 among its holdings. This is a return to the name: Bennett Lawrence Management previously reported a position in PCRX as recently as Q1 2015.

Bennett Lawrence Management first reported a position in PCRX in Q1 2015 and has held it in 2 quarters since. 214 funds tracked by Wall St. Rank hold PCRX as of Q4 2015.

  • Bennett Lawrence Management held 6,230 shares of Pacira BioSciences worth $478K as of Q4 2015.
  • Pacira BioSciences was a new Bennett Lawrence Management position in Q4 2015.
  • Pacira BioSciences made up 0.15% of Bennett Lawrence Management's portfolio in Q4 2015, its #83 holding.
  • Bennett Lawrence Management first reported a position in Pacira BioSciences in Q1 2015 and has held it in 2 quarters since.
  • 214 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2015.

Based on Bennett Lawrence Management's 13F filing for Q4 2015, filed 16 Feb 2016.